{"id":"W2159179344","doi":"10.1093/annonc/mdu141","title":"Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":604,"is_retracted":false,"has_abstract":false,"ca_institutions":"Credit Valley Hospital; Mount Sinai Hospital","funders":"","keywords":"Medicine; Panitumumab; KRAS; Internal medicine; Hazard ratio; Colorectal cancer; Clinical endpoint; Randomized controlled trial; Oxaliplatin; Confidence interval; Oncology; Adverse effect; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003633903,0.0002285454,0.002333563,0.0001048388,0.00005567128,0.000001831522,0.00006535555,0.00005485798,0.00004356536],"category_scores_gemma":[0.0002835148,0.0001376307,0.0002388195,0.0001306345,0.0002524133,0.00002787587,0.00002350144,0.00004308587,3.722904e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008348451,"about_ca_system_score_gemma":0.0002803397,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005204723,"about_ca_topic_score_gemma":0.007508767,"domain_scores_codex":[0.9982392,0.0001671035,0.0008556676,0.0003080136,0.0002101305,0.0002198834],"domain_scores_gemma":[0.9966061,0.001841361,0.0007536445,0.0002136377,0.000513322,0.00007196411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.861491,0.01879717,0.001070982,0.00007075431,0.006666163,0.00002406975,0.008293414,0.00006825875,0.0006047694,0.00003324783,0.0002846929,0.1025955],"study_design_scores_gemma":[0.7819562,0.1851725,0.003532069,0.000098597,0.003484737,0.000004714266,0.0009435942,0.0004660705,0.02163986,0.0001542188,0.002423671,0.0001238134],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930429,0.00122658,0.0001412222,0.001121285,0.0001005512,0.003205214,0.000506847,0.00001106682,0.0006443138],"genre_scores_gemma":[0.9971752,0.0008798633,0.0006250475,0.0000544591,0.00007490952,0.000931768,0.00008935799,0.00001669177,0.0001527459],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1663753,"threshold_uncertainty_score":0.7868019,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1282057758737968,"score_gpt":0.4285832052192958,"score_spread":0.300377429345499,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}